Answers are grounded in this paper and cite their sources.
This review discusses the role of adipose-derived stem cell secretome in promoting healing of diabetic foot ulcers, indicating its clinical potential.
Diabetic foot ulcers (DFUs) are chronic wounds and one of the most common complications of diabetes, imposing significant physical and mental burdens on patients due to their poor prognosis and treatment efficacy. Adipose-derived stem cells (ADSCs) have been proven to promote wound healing, with studies increasingly attributing these beneficial effects to their paracrine actions. Consequently, research on ADSC secretome as a novel and promising alternative for DFU treatment has been extensively conducted. This article provides a comprehensive review of the mechanisms underlying refractory DFU wounds, the secretome of ADSCs, and its role in promoting wound healing in diabetes foot ulcers. And the review aims to provide reliable evidence for the clinical application of ADSC secretome in the treatment of refractory DFU wounds.
No takes yet. Share an insight, caveat, or question.
Wan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: